cisplatin-ineligible
Showing 1 - 25 of 2,831
Metastatic Malignancy Trial in Houston (Atezolizumab, Tiragolumab)
Not yet recruiting
- Metastatic Malignancy
-
Houston, TexasM D Anderson Cancer Center
Dec 19, 2022
Metastatic Urothelial Carcinoma Trial in Tampa, Boston (Ipilimumab, Nivolumab, Sacituzumab govitecan)
Recruiting
- Metastatic Urothelial Carcinoma
- Ipilimumab
- +2 more
-
Tampa, FloridaMoffitt Cancer Center
Jan 24, 2023
Cisplatin-Ineligible Metastatic Bladder Cancer and The Role of
Not yet recruiting
- Bladder Cancer
- +3 more
- Geriatric-8 Survey
- +2 more
-
Boston, Massachusetts
- +1 more
Nov 14, 2023
Bladder Cancer Trial in Fairway, Kansas City (Ascorbic Acid)
Active, not recruiting
- Bladder Cancer
- Ascorbic Acid
-
Fairway, Kansas
- +2 more
Sep 21, 2022
Metastatic Urothelial Carcinoma, Bladder Cancer Trial in Tampa, Atlanta, Salt Lake City (Cabozantinib, Pembrolizumab)
Recruiting
- Metastatic Urothelial Carcinoma
- Bladder Cancer
-
Tampa, Florida
- +2 more
Jun 9, 2022
Advanced Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma Trial in Sacramento
Recruiting
- Advanced Urothelial Carcinoma
- +3 more
- Pembrolizumab
- Selinexor
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Jun 28, 2022
Bladder Cancer Trial in United States (Nivolumab, Nivolumab/Lirilumab)
Completed
- Bladder Cancer
-
Tampa, Florida
- +7 more
Nov 4, 2022
Urothelial Carcinoma Bladder Trial in Houston (drug, radiation, procedure)
Recruiting
- Urothelial Carcinoma Bladder
- Sasanlimab
- +2 more
-
Houston, TexasHouston Methodist Hospital
Feb 15, 2022
Cancer of Head and Neck Trial in Hannover (Pembrolizumab Injection, Methotrexate Injectable Solution)
Active, not recruiting
- Cancer of Head and Neck
- Pembrolizumab Injection
- Methotrexate Injectable Solution
-
Hannover, GermanyMedizinsche Hochschule Hannover
Dec 14, 2021
Bladder Transitional Cell Carcinoma, Bladder Cancer, Fibroblast Growth Factor Receptor Trial (Infigratinib)
Withdrawn
- Bladder Transitional Cell Carcinoma
- +2 more
- (no location specified)
Aug 8, 2022
Urothelial Carcinoma, Bladder Cancer Trial in Zhengzhou (Toripalimab, Gemcitabine)
Recruiting
- Urothelial Carcinoma
- Bladder Cancer
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital
Nov 24, 2021
Urothelial Carcinoma, Bladder Cancer, Transitional Cell Carcinoma Trial in United States (nab-paclitaxel, Gemcitabine)
Terminated
- Urothelial Carcinoma
- +2 more
-
Fort Myers, Florida
- +4 more
Dec 15, 2021
Urothelial Carcinoma Trial in United States (Carboplatin, Gemcitabine, Atezolizumab)
Active, not recruiting
- Urothelial Carcinoma
- Carboplatin
- +3 more
-
Indianapolis, Indiana
- +3 more
Feb 14, 2022
Head and Neck Carcinoma of Unknown Primary, Locally Advanced Head and Neck Squamous Cell Carcinoma, Locally Advanced
Recruiting
- Head and Neck Carcinoma of Unknown Primary
- +5 more
- Tolinapant
- Radiation Therapy
-
Atlanta, GeorgiaEmory University/Winship Cancer Institute
Feb 17, 2022
Metastatic Urothelial Cancer Trial in United States (Nivolumab, Gemcitabine, Carboplatin)
Active, not recruiting
- Metastatic Urothelial Cancer
- Nivolumab
- +3 more
-
Baltimore, Maryland
- +5 more
Sep 7, 2021
Bladder Carcinoma, Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma Trial in Toronto (biological, procedure,
Recruiting
- Bladder Carcinoma
- +7 more
- Atezolizumab
- +5 more
-
Toronto, Ontario, CanadaUniversity Health Network Princess Margaret Cancer Center LAO
Nov 8, 2022
Head Neck Cancer, Head and Neck Tumors, Squamous Cell Carcinoma of Head and Neck Trial in Chicago (Xevinapant, Carboplatin,
Not yet recruiting
- Head and Neck Cancer
- +2 more
- Xevinapant
- +3 more
-
Chicago, IllinoisUniversity of Chicago Medicine Comprehensive Cancer Center
Oct 25, 2023
Bladder Cancer, Urothelial Carcinoma Trial in Porto Alegre (Olaparib, Durvalumab)
Terminated
- Bladder Cancer
- Urothelial Carcinoma
-
Porto Alegre, BrazilCentro de Pesquisa em Oncologia
Jun 14, 2021
Urothelial Bladder Carcinoma Trial in Spain (Sacituzumab govitecan, Zimberelimab, Domvanalimab)
Not yet recruiting
- Urothelial Bladder Carcinoma
- Sacituzumab govitecan
- +2 more
-
Santiago De Compostela, A Coruña, Spain
- +9 more
Nov 14, 2023
Squamous Cell Carcinoma of the Head and Neck Trial in Worldwide (biological, drug, radiation)
Completed
- Squamous Cell Carcinoma of the Head and Neck
- Nivolumab
- +3 more
-
Anniston, Alabama
- +54 more
Aug 5, 2021
Urinary Bladder Tumor, Tumor Metastasis Trial in Worldwide (Bempegaldesleukin, Nivolumab)
Completed
- Urinary Bladder Neoplasm
- Neoplasm Metastasis
- Bempegaldesleukin
- Nivolumab
-
San Francisco, California
- +69 more
Jul 22, 2022